These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10697746)

  • 21. French Haemovigilance Data on Platelet Transfusion.
    Willaert B; Vo Mai MP; Caldani C
    Transfus Med Hemother; 2008; 35(2):118-121. PubMed ID: 21512639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inspection of transfusion sites by the French Blood Establishment].
    Chevrolle F; Hadzlik E; Suchel PL
    Transfus Clin Biol; 2001 Dec; 8(6):485-9. PubMed ID: 11802612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological surveillance of infectious diseases in France.
    Dufour B; La Vieille S
    Vet Res; 2000; 31(2):169-85. PubMed ID: 10779198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ultimate pre-transfusion control: evaluation of seven appliances].
    Tramalloni D; Hatteville L; Oubouzar N; Hartmann O; Lapierre V
    Transfus Clin Biol; 2000 Apr; 7(2):129-39. PubMed ID: 10812657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European Court of Justice. ECJ 2014/6 Octapharma France SAS v. Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), Ministère des Affaires Sociales et de la Santé, 13 March 2014 (C-512/12).
    Baeyens A; Goffin T
    Eur J Health Law; 2014 Jun; 21(3):317-21. PubMed ID: 25065041
    [No Abstract]   [Full Text] [Related]  

  • 26. [Not Available].
    ; Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB
    Therapie; 2011; 66(6):517-25. PubMed ID: 27393472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 2 diabetes treatment: French recommendations for good practice AFSSAPS - HAS.2006.
    Diabetes Metab; 2006 Dec; 32(6):643-8. PubMed ID: 17312575
    [No Abstract]   [Full Text] [Related]  

  • 28. [European Community procedure of marking for a reagent. Application to HIV 1 and 2 detection kits].
    Bénichou-Debasc K; Gautheret-Dejean A
    Virologie (Montrouge); 2009 Jun; 13(3):171-179. PubMed ID: 36151670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adaptation of the clinical trials directive: recommendations on the contents of a dossier for the request for authorisation of the first trials in human subjects.
    Bélorgey C; Plétan Y; Goehrs JM;
    Therapie; 2004; 59(3):329-47. PubMed ID: 15559187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quality control of reactant lots at the Nation Blood Group Reference Center (CNRGS). Data for the year 1998].
    Noizat-Pirenne F; Le Pennec PY; Rouger P
    Transfus Clin Biol; 1999 Jun; 6(3):195-200. PubMed ID: 10422213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collaboration Between Health-Care Professionals, Patients, and National Competent Authorities Is Crucial for Prevention of Health Risks Linked to the Inappropriate Use of Drugs: A Position Paper of the ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé).
    Vignot S; Daynes P; Bacon T; Vial T; Montagne O; Albin N; Emmerich J; Ratignier-Carbonneil C; Martin D; Maison P
    Front Pharmacol; 2021; 12():635841. PubMed ID: 33995037
    [No Abstract]   [Full Text] [Related]  

  • 32. Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?
    Faillie JL; Petit P; Montastruc JL; Hillaire-Buys D
    Drug Saf; 2013 Sep; 36(9):693-707. PubMed ID: 23868339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The German Program for Disease Management Guidelines Type 2 Diabetes - Diabetic Foot Guideline 2006. Short review].
    Ollenschläger G; Kopp I; Thole H; Lelgemann M;
    Med Klin (Munich); 2007 Mar; 102(3):250-4. PubMed ID: 17345021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Report of adverse events related to treatments to Institute de Veille sanitaire].
    Maingon P; Simmon-Tellier S
    Cancer Radiother; 2007 Nov; 11(6-7):317-9. PubMed ID: 17870628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommendations regarding obesity surgery.
    Laville M; Romon M; Chavrier G; Guy-Grand B; Krempf M; Chevallier JM; Marmuse JP; Basdevant A
    Obes Surg; 2005; 15(10):1476-80. PubMed ID: 16354530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The "Société française d'Histoire de la Médecine" and the "Service de santé des armées"].
    Plessis JL
    Hist Sci Med; 2003; 37(3):311-8. PubMed ID: 14621700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current features of food allergies: the need of allergy surveillance].
    Moneret-Vautrin DA
    Bull Acad Natl Med; 2001; 185(5):943-57; discussion 958-62. PubMed ID: 11717849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empowerment in diabetes care: towards measuring empowerment.
    Sigurdardottir AK; Jonsdottir H
    Scand J Caring Sci; 2008 Jun; 22(2):284-91. PubMed ID: 18298619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementing the American Diabetes Association's nutrition recommendations.
    Leontos C
    J Am Osteopath Assoc; 2003 Aug; 103(8 Suppl 5):S17-20. PubMed ID: 12962206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Not Available].
    Mamzer MF; Dubois S; Saout C;
    Therapie; 2018 Feb; 73(1):83-93. PubMed ID: 29429552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.